David Woloviec is the founder and Chief Growth Architect at DG Volo & Company. David draws on more than 20 years’ experience in the strategy consulting and private equity sectors to deliver transformative growth solutions to private equity-owned portfolio companies. Earlier in his career, David was an Associate Partner with Oliver Wyman, where he specialized in business design and commercial strategy. He then went on to become Chief Sales & Marketing Officer of The Harvard Drug Group, a private equity-owned portfolio of seven companies serving the US healthcare sector.
David holds an M.B.A (High Distinction) from the Ross School of Business at the University of Michigan, and a B.A.Sc. (Industrial Engineering) from the Faculty of Applied Science & Engineering at the University of Toronto.